Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.-H. Peng
Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation
Cancer Research
Cancer Research
Oncology
Related publications
Hydrodynamic Shear Rate Regulates Melanoma-Leukocyte Aggregation, Melanoma Adhesion to the Endothelium, and Subsequent Extravasation
Annals of Biomedical Engineering
Biomedical Engineering
Context-Dependent Roles of Mutant B-Raf Signaling in Melanoma and Colorectal Carcinoma Cell Growth
Molecular Cancer Therapeutics
Cancer Research
Oncology
FOXD3 Is a Mutant B-Raf-Regulated Inhibitor of G1-S Progression in Melanoma Cells
Cancer Research
Cancer Research
Oncology
Reactivation of Mitogen-Activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-Raf V600E Mutant Melanoma
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
Clinical Cancer Research
Cancer Research
Oncology
A New B-Raf Inhibitor Combo for Advanced Melanoma
Oncotarget
Oncology
Clinicopathologic Features of V600E and V600K Melanoma--Response
Clinical Cancer Research
Cancer Research
Oncology
AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Targeting Metastatic Melanoma
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
